3 Einträge gefunden

1. Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

   1. Canon, Jean-Luc
   2. Vansteenkiste, Johan
   3. Hedenus, Michael
   4. Gascon, Pere
   5. Bokemeyer, Carsten
   6. Ludwig, Heinz
   7. Vermorken, Jan

   2012 - Forschungsinformationssystem des UKE
2. Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level <10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.

   1. Vansteenkiste, Johan
   2. Hedenus, Michael
   3. Gascon, Pere
   4. Bokemeyer, Carsten
   5. Ludwig, Heinz
   6. Vermorken, Jan
   7. Hamilton, Lisa

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
3. Erythropoietins should be used according to guidelines.

   1. Aapro, Matti S
   2. Birgegård, Gunnar
   3. Bokemeyer, Carsten
   4. Cornes, Paul
   5. Foubert, Jan
   6. Gascon, Pere
   7. Glaspy, John

   2008 - Forschungsinformationssystem des UKE